(Q33234917)
Statements
Tolerability of intensified intravenous interferon alfa-2b versus the ECOG 1684 schedule as adjuvant therapy for stage III melanoma: a randomized phase III Italian Melanoma Inter-group trial (IMI - Mel.A.) [ISRCTN75125874] (English)
Antonella Romanini
Michele Guida
Adriano Paccagnella
Maurizio Dalla Palma
Emanuele Naglieri
Ruggero Ridolfi
Barbara Silvestri
Maria Michiara
27 February 2006
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference